ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Helius Medical Technologies Inc

Helius Medical Technologies Inc (HSDT)

5.83
0.23
(4.11%)
At close: March 28 04:00PM
5.65
0.05
( 0.89% )
After Hours: 05:37PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.65
Bid
5.66
Ask
5.98
Volume
10,615
5.58 Day's Range 5.90
4.29 52 Week Range 14.44
Market Cap
Previous Close
5.60
Open
5.79
Last Trade
1
@
5.84
Last Trade Time
17:55:38
Financial Volume
$ 61,374
VWAP
5.7818
Average Volume (3m)
331,034
Shares Outstanding
708,247
Dividend Yield
-
PE Ratio
-0.29
Earnings Per Share (EPS)
-19.87
Revenue
787k
Net Profit
-14.07M

About Helius Medical Technologies Inc

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Ne... Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
Vancouver, British Columbia, Can
Founded
1970
Helius Medical Technologies Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker HSDT. The last closing price for Helius Medical Technolog... was $5.60. Over the last year, Helius Medical Technolog... shares have traded in a share price range of $ 4.29 to $ 14.44.

Helius Medical Technolog... currently has 708,247 shares outstanding. The market capitalization of Helius Medical Technolog... is $4.13 million. Helius Medical Technolog... has a price to earnings ratio (PE ratio) of -0.29.

HSDT Latest News

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

NEWTOWN, Pa., March 15, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic...

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month Study will evaluate the use of Portable Neuromodulation Stimulator (PoNS®) for gait and balance deficits in...

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic...

Form 8-K - Current report

0001610853falseDE00016108532024-03-042024-03-04​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the...

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances...

Form 8-K - Current report

0001610853falseDE00016108532024-02-062024-02-06​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-0.8771929824565.76.05415.587575.70093433CS
41.2127.25225225234.446.984.424460615.78406742CS
12-2.41-29.90074441698.069.54.293310346.13072788CS
26-3.01-34.75750577378.669.894.291608026.20444683CS
52-6.85-54.812.514.444.293642338.53802728CS
156-911.35-99.38386041449179554.2968289241.17916015CS
260-11841.85-99.952310614111847.511987.54.29560901381.16588701CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.04
(50.75%)
2.73M
GRTXGalera Therapeutics Inc
$ 0.1732
(23.71%)
965.43k
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.38k
SBFMSunshine Biopharma Inc
$ 0.0715
(18.18%)
24.13M
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.6499
(-34.36%)
1.23M
NVVENuvve Holding Corporation
$ 0.805
(-26.82%)
112.2k
NDRAENDRA Life Sciences Inc
$ 0.455
(-21.55%)
123.87k
MVLAMovella Holdings Inc
$ 0.0501
(-19.71%)
489.27k
KYCHKeyarch Acquisition Corporation
$ 10.06
(-18.21%)
9k
SBFMSunshine Biopharma Inc
$ 0.0715
(18.18%)
24.13M
CRKNCrown Electrokinetics Corporation
$ 0.0621
(3.67%)
6.57M
AAPLApple Inc
$ 171.44
(-0.02%)
3.54M
JAGXJaguar Health Inc
$ 0.08705
(-3.17%)
3.01M
CISSC3is Inc
$ 0.0342
(-1.72%)
2.88M

HSDT Discussion

View Posts
BurgerKing82 BurgerKing82 2 weeks ago
Besides SS...anything promising about this 1?
👍️0
Invest-in-America Invest-in-America 3 weeks ago
HSDT: So-called "Medical Research" firms producing NONSENSE gadgets like this should be put in DEATH CAMPS --- along with the 'inventor' of the "NAVAGE" garden hose up one's NOSE!! They are MORONS!! (Fix the UNDERLYING physiological-cellular-GENOMIC problems, you Homo sapiens SHITHEADS!!!)
👍️0
Invest-in-America Invest-in-America 3 weeks ago
HSDT: I wouldn't want THAT absurd gadget in my MOUTH, anymore than I'd want a "NAVAGE" in my NOSE, nor up my ASS!!! (What a Medically-IGNORANT Planet we all live on!!!!)
👍️0
TheFinalCD TheFinalCD 3 weeks ago
HSDT Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller $HSDT https://t.co/aLSe41iOov— Health Stocks News (@health_stocks) March 4, 2024
👍️0
Awl416 Awl416 3 weeks ago
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
👍️0
subslover subslover 3 weeks ago
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) --

-- Proceeds from recent stock issuances through the Company’s At-The-Market (“ATM”) program extends cash runway into the third quarter 2024 --

NEWTOWN, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has assigned Healthcare Common Procedure Coding System (“HCPCS”) Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece. The new HCPCS codes will be effective April 1, 2024.

“PoNS Therapy® is life-changing for people who suffer gait impairment due to MS and we’re pleased that CMS understood the benefits of this innovative treatment by establishing HCPCS codes for both the PoNS mouthpiece and controller. This marks a critical reimbursement and access milestone and provides Helius the ability to begin negotiating reimbursement with third-party payers using these unique HCPCS codes. We believe there is a reasonable likelihood that at the public meetings this summer CMS will determine a reimbursement amount for each of the PoNS controller and mouthpiece to take effect on October 1, 2024,” stated Helius’ President and Chief Executive Officer, Dane Andreeff.

“As we pursue widespread reimbursement for PoNS Therapy, we have continued to manage our cash burn. With the recently announced $1.5 million of net proceeds from the sale of shares of our common stock under our ATM program at an average share price of $9.17 per share, our cash runway has been extended into the third quarter of this year. Once we establish reimbursement for PoNS, we believe we will be able to expand reimbursement across third-party payers and have a pathway to positive cash flow as we continue to pursue authorization for stroke in the U.S.,” concluded Andreeff.

PoNS is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from MS and is to be used as an adjunct to a supervised therapeutic exercise program. The Company is also seeking marketing authorization under PoNS’s breakthrough designation for stroke in the United States, where over five million stroke survivors are affected by walking and balance disability. In Canada, PoNS is authorized to treat balance impairment due to MS, stroke and mild-to-moderate traumatic brain injury.

About Helius Medical Technologies, Inc.
👍️0
Monksdream Monksdream 2 months ago
The pr pump then the dump
👍️0
subslover subslover 2 months ago
As of November 3, 2023, the registrant had 708,247 shares of Class A common stock, $0.001 par value per share, outstanding.
👍️0
TheFinalCD TheFinalCD 2 months ago
traded it but made very little money

feels wonky
👍️0
subslover subslover 2 months ago
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
-- Studies uses Portable Neuromodulation Stimulator (PoNS®) to evaluate cranial-nerve non-invasive neuromodulation for gait/balance deficits in stroke patients --

-- Interaction with FDA on clinical program feasibility streamlines cost and timeline and leverages trials with the Medical University of South Carolina and Brooks Rehabilitation --

-- Studies and real-world evidence results will be submitted for regulatory authorization under PoNS’s breakthrough designation for stroke --

-- Regulatory submission for stroke and marketing authorization expected in 2025 --

NEWTOWN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today that it has concluded its interaction with the U.S. Food and Drug Administration (“FDA”) on optimizing the development plan for its stroke program which aims to evaluate the effects of cranial-nerve non-invasive neuromodulation (“CN-NINM”) delivered using PoNS Therapy® on gait and dynamic balance in chronic stroke survivors. Helius’ registrational program includes two controlled studies. The clinical program will leverage a randomized, controlled, double blinded investigator-initiated trial (“IIT”), led by Dr. Steven Kautz at the Medical University of South Carolina (“MUSC”) and a Company-sponsored study to enroll approximately 100 subjects. Dr. Kautz’s IIT began enrollment of 60 participants in September 2023 with the collaboration of Dr. Mark Bowden at Brooks Rehabilitation as a second site.

“Vetting the registrational program and design of our clinical studies with the FDA is an important milestone for Helius and meeting the agency’s expectations will give us the most efficient path to delivering PoNS Therapy to stroke patients,” said Dr. Antonella Favit-Van Pelt, Helius’ Chief Medical Officer. “This development plan, which leverages early study results and real-world evidence from Canada, allows us to streamline the size, timeline, and cost of the registrational program and positions Helius on the best course toward potential FDA authorization under PoNS’s breakthrough designation for stroke.”

When evaluated in a real-world evidence (RWE) database analysis of Canadian stroke patients with gait or balance deficit, PoNS Therapy demonstrated a significant and clinically meaningful improvement in gait, averaging a 6.74-point improvement in the functional gait assessment (FGA) score over a 14-wk treatment period (95% CI: 4.85 to 8.63). Before starting PoNS Therapy, over 93% of patients were considered at risk of falling, as determined by an FGA
👍️0
Awl416 Awl416 2 months ago
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
👍️0
tw0122 tw0122 2 months ago
Pump it up
👍️0
DollarDan DollarDan 4 months ago
I am guessing this is not the platform to talk about HSDT stock seeing as no one has been here for a while.
👍️0
ckmseven788 ckmseven788 7 months ago
Interesting. Hopefully they announce FDA approval and/or Medicaid coverage on PONS, or some kind news catalyst. There’s got to be a reason the CEO has been loading. Plus, this past Monday there was a major shift in dollar volume. 200 million dollars traded that day, then every day after that at least a couple million traded. HSDT has never even been close to volume like that. I got a feeling something is brewing.
👍️0
dinogreeves dinogreeves 7 months ago
They don't have much in the books, they are going to do it soon, they only had 8.5 million as of the end of June and each quarter goes by 3.5 million dollars negative in the books and 250,000 dollars in sales, that is nothing, yes true that they don't have any debt, but what else do they have to show for other that 250,000 dollars in sales, that is not enough to cover expenses. 15-20 is the target to get out, anything more than that you are asking for trouble.
👍️0
ckmseven788 ckmseven788 7 months ago
All it’s saying is they have the right to add more shares to the total shares outstanding if they choose. They shouldn’t have to do that since they have cash and zero debt, but even if they do one would think they would do it at a much higher PPS then here…
👍️0
dinogreeves dinogreeves 7 months ago
They have not been in effect yet.

https://www.sec.gov/Archives/edgar/data/1610853/000110465923064633/tm2315565-1_s3a.htm

https://www.sec.gov/Archives/edgar/data/1610853/000110465923074253/tm2319321-1_424b5.htm
👍️0
ckmseven788 ckmseven788 7 months ago
Can you post a link to this?
👍️0
tw0122 tw0122 7 months ago
Nice runner small float now
👍️0
dinogreeves dinogreeves 7 months ago
I jumped in yesterday on this, Tuesday could hit 15-20, At the Market prospectus has been filed a little while ago for close to 2 million dollars. I won't ask for anything more than 20. Good luck everyone.
👍️0
Jess070283 Jess070283 7 months ago
$20+ tomorrow IMO
👍️0
Awl416 Awl416 7 months ago
Bye bye float. The fact I got filled on the bid today. All about timing

TGIF - enjoy your long weekend all
👍️0
yankees18 yankees18 7 months ago
Has a few gaps to fill on the way up!!
👍️0
Awl416 Awl416 7 months ago
Fun isn’t it
👍️0
saj saj 7 months ago
Boom!
👍️0
TheFinalCD TheFinalCD 7 months ago
$HSDT RS https://finance.yahoo.com/news/helius-medical-technologies-announces-reverse-130000309.html

Helius Medical Technologies Announces Reverse Stock Split - Health Stocks Hub $HSDT https://t.co/OHVzF0DrIE— Health Stocks News (@health_stocks) August 16, 2023
👍️0
heyitsmeagain heyitsmeagain 11 months ago
Sold
👍️0
heyitsmeagain heyitsmeagain 11 months ago
IS IT FINALLY TIME?
👍️0
kzivann kzivann 1 year ago
Premarket volume on news. PPS up a bit?

HSDT
👍️0
ckmseven788 ckmseven788 1 year ago
This one is looking good
👍️0
Imokhopeur Imokhopeur 1 year ago
Had to grab a few
👍️0
missile_systems missile_systems 2 years ago
OMG… Maine !
Sounds like a hidden gem Brother.
Never been that far north. I’m in the Philly / South Jersey area and our winters are no picnic but the area you mentioned is a whole other league LOLOL!!! The winters have to be brutal, but, if push comes to shove … that sounds like a great spot to bug out !!!!
Good night… talk soon.

mis
👍️0
subslover subslover 2 years ago
OMG brother you are so right on with that statement. I know a great location in NW Maine called Moosehead lake. just a few peps live there and it's so secluded that nobody knows how to get there. All the roads are dirt. I went there with my EX Wife years ago and stayed in a cabin on the lake. Many bears and Moose live there so you need their permission to stay. I can't imagine what the winters are like there. I don't even know if they have cell or internet service. lol
👍️0
subslover subslover 2 years ago
Very cool, I will respond back to your PM early Saturday. Email and phone #
👍️0
missile_systems missile_systems 2 years ago
Yes Sir my family and I are ok .
These certainly are worrisome times my friend.
A generator, some long term survival food and a shotgun or two are highly recommended.

Hopefully you and yours are ok and prepared as well.
God Bless !

mis
👍️0
missile_systems missile_systems 2 years ago
Thanks soo much my friend.
I will send you a d m on Friday happy hour ihub service.
Very much appreciate ya !!!!
👍️0
subslover subslover 2 years ago
Hello, my friend missile_systems! I would not chase this because it's very volitle. If she drops back to where she had been trading then maybe. I have several others I like so send me an email.
Hope you and yours are doing well in this day and age of uncertainty
👍️0
subslover subslover 2 years ago
Hello, my friend missile_systems! I would not chase this because it's very volitle. If she drops back to where she had been trading then maybe. I have several others I like so send me an email.
Hope you and yours are doing well in this day and age of uncertainty
👍️0
missile_systems missile_systems 2 years ago
Hi Subsy!
Is this ticker any good in your opinion?
I can’t get a win to save my life Lolol….
Thanks for your help Brother!
👍️0
missile_systems missile_systems 2 years ago
Hi Subsy!
Is this ticker any good in your opinion?
I can’t get a win to save my life Lolol….
Thanks for your help Brother!
👍️0
Invest-in-America Invest-in-America 2 years ago
Hey, THANKS for that paltry INCOME link, Bro!!
👍️0
Invest-in-America Invest-in-America 2 years ago
WHAT?? You gots IN-&-OUT in a microsecond???

👍️0
TheFinalCD TheFinalCD 2 years ago
https://ih.advfn.com/stock-market/NASDAQ/helius-medical-technolog-HSDT/stock-news/88898155/coverage-initiation-with-bullish-price-target-caus

but keep in mind https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169688043
👍️0
subslover subslover 2 years ago
Just in - out like the last time!
👍️0
Invest-in-America Invest-in-America 2 years ago
And they gots some WARRANTS, for what that's worth --- in passing.
👍️0
Invest-in-America Invest-in-America 2 years ago
THANKS!!
👍️0
subslover subslover 2 years ago
Helius Medical Technologies: A Net-Net Meme Stock In The Making
Aug. 23, 2022 8:03 AM ETHelius Medical Technologies, Inc. (HSDT)
Summary
A curious $14.5m microcap that $100m in value has transacted through in just 15 trading sessions.
A recent equity raise increased cash position by $16.4m in August. The company is currently net-net trading below net current asset value. P/B is 0.69x.
Shorts are likely to be forced to cover in the next two months given high cost to borrow rate of 558% currently, second highest amongst US stocks.
With Reddit retail investors piling in and billionaire hedge funds involved, I think we have a meme stock in the making poised for a volatile short squeeze.
👍️0
MASTERULTRA MASTERULTRA 2 years ago
Can someone please explain to me why the company hasn't PR about closed offering they just had?
👍️0
S3lfMade S3lfMade 2 years ago
Could be on its way to teens with numbers like these imo
👍️0
S3lfMade S3lfMade 2 years ago
Earnings out.. $119,000 in rev last 3 months...
👍️0

Your Recent History

Delayed Upgrade Clock